Offerings
Products
Distribution Products
- Mutual Funds
- Basket Investing
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Markets
Stocks
F&O
Mutual Funds
ETFs
More
Research
Pricing
Resources

Sector: Pharmaceuticals & Biotechnology

Small Cap

MPS Pharma Share Price

Q: What is the Market Capitalization of MPS Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 2 June 2025, the market cap for MPS Pharma Ltd. is approximately ₹ 3.2 Cr.

Q: What are the PE and PB ratios for MPS Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for MPS Pharma Ltd. is -3.4, and the Price-to-Book (PB) ratio is 7.4.

Q: What is the 52-Week High and Low for MPS Pharma Ltd.?

Over the past 52 weeks, the highest price reached by MPS Pharma Ltd. shares was ₹ 3.17, and the lowest price was ₹ 1.57.

Q: Who are the major shareholders of MPS Pharma Ltd.?

Significant shareholdings in MPS Pharma Ltd. typically include entities such as: Public Promoter Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of MPS Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, MPS Pharma Ltd. is often compared with other major players such as Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs and Corona Remedies for analysis and benchmarking.

MPS Pharma Ltd.

₹0

0(0%)

Trade Now

No Graph

NSE :

Open Free Demat Account

MPS Pharma Performance

Price Movement

N/A

₹0.00

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹0.00

Low₹0.00

Open at₹0.00

Prev Close₹0.00

Volumes0

Avg Price₹0.00

Lower Circuit₹0.00

Upper Circuit₹0.00

Historical Performance

3M High₹1.76

3M Low₹1.57

1 Yr High₹3.17

1 Yr Low₹1.57

3 Yr High₹4.33

3 Yr Low₹1.57

5 Yr High₹4.33

5 Yr Low₹0.89

MPS Pharma Fundamentals

Market Cap

3.20 Cr.

PE Ratio (TTM)

Negative PE TTM

-3.40

Dividend Yield

Net Profit TTM

9% decr over last year

-0.94

Net Profit Growth

9% decr over last year

-0.94

PEG Ratio

Above industry Median

0.40

ROE

97% decr over last year

-83.08

Operating Revenue TTM

Operating Revenue Growth

Book Value

High in industry

7.40

MFI

MFI is mid-range

31.11

RSI

RSI oversold

27.71

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

7.40

MPS Pharma Financials

Data not available for chart

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	0	0	0	0	0
Operating Expense	0.19	0.19	0.19	0.19	0.18
Operating Profit	-0.19	-0.19	-0.19	-0.19	-0.18
Depreciation	0.04	0.04	0.04	0.04	0.04
Interest	0	0	0	0	0
Tax	-0.01	-0.01	-0.01	0.05	0
Net Profit	-0.22	-0.22	-0.22	-0.28	-0.17

MPS Pharma Technicals

MPS Pharma Ltd. EMA & SMA

₹1.65

0.00 (0.00%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1.7

Day EMA10 ₹1.7

Day EMA12 ₹1.7

Day EMA20 ₹1.8

Day EMA26 ₹1.9

Day EMA50 ₹2.3

Day EMA100 ₹2.5

Day EMA200 ₹2.4

MPS Pharma Support and Resistance

Resistance

First Resistance₹1.65

Second Resistance₹1.65

Third Resistance₹1.65

Support

First Support₹1.65

Second Support₹1.65

Third Support₹1.65

Technical Indicators

Day RSI27.71

Day MFI31.11

Day ADX49.76

Day Commodity Channel Index-93.50

William-71.43

Day MACD-0.20

Day MACD Signal Line-0.22

Day ATR0.08

Day ROC125-31.82

Day ROC21-17.09

MPS Pharma Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	35.9	35.9	35.9	35.9	35.9	35.9
FII	0	0	0	0	0	0
DII	0.6	0.6	0.6	0.6	0.6	0.6
Public	63.5	63.5	63.5	63.5	63.5	63.5

MPS Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	520	520	100.00%
Week	0	0	undefined%
1 Month	0	0	undefined%
6 Month	1.61 K	1.61 K	100.00%

MPS Pharma SWOT Analysis

Strengths3

Weakness12

Opportunity0

Threats0

PEG lower than Industry PEG

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Stock with Low PE (PE < = 10)

MPS Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

MPS Pharma Stock Comparison

Financials	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.	Aptus Pharma Ltd.
Price (₹)	₹425	₹147.95	₹209.50	₹39.09	₹7.01	₹355
% Change	0.77%	4.97%	2.62%	1.98%	4.94%	1.43%
Revenue TTM (₹ Cr)	-	-	-	₹0.54	₹83.60	-
Net Profit TTM (₹ Cr)	-	-	-	₹-0.24	₹-34.95	-
PE TTM	-	15.10	56.30	-99.40	-1.70	78.60
1 Year Return	7.83			768.67	601
ROCE	28.91	-	-	-	-5.63	-

Similar Stocks

AMANTA

Amanta Healthcare Ltd.

₹ 105.93

-3.20%

AHCL

Anlon Healthcare Ltd.

₹ 122.50

+2.60%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 77.00

-0.43%

APL

Asston Pharmaceuticals Ltd.

₹ 87.29

+14.84%

PHRMASI

Phaarmasia Ltd.

₹ 88.94

+0.00%

MEDICAPQ

MediCaps Ltd.

₹ 27.85

+0.87%

GENESIS

Genesis IBRC India Ltd.

₹ 83.18

+0.00%

VEERHEALTH

Veerhealth Care Ltd.

₹ 20.97

+0.00%

VIVOBIOT

Vivo Bio Tech Ltd.

₹ 26.10

+0.35%

GUFICBIO

Gufic BioSciences Ltd.

₹ 302.90

+0.97%

JAGSNPHARM

Jagsonpal Pharmaceuticals Ltd.

₹ 194.00

+0.26%

GUJTHEM

Gujarat Themis Biosyn Ltd.

₹ 282.00

+1.01%

MAKERSL

Makers Laboratories Ltd.

₹ 156.15

-1.01%

UNICHEMLAB

Unichem Laboratories Ltd.

₹ 337.00

+1.40%

FERMENTA

Fermenta Biotech Ltd.

₹ 335.00

+0.01%

ANUHPHR

Anuh Pharma Ltd.

₹ 78.50

+0.59%

BLISSGVS

Bliss GVS Pharma Ltd.

₹ 253.89

-0.07%

PARNAXLAB

Parnax Lab Ltd.

₹ 138.10

-2.92%

NOVARTIND

Novartis India Ltd.

₹ 990.05

-0.13%

MOREPENLAB

Morepen Laboratories Ltd.

₹ 39.59

-0.05%

LYKALABS

Lyka Labs Ltd.

₹ 58.10

-0.22%

AMBALALSA

Ambalal Sarabhai Enterprises Ltd.

₹ 28.80

+0.14%

ACCPL

Accretion Pharmaceuticals Ltd.

₹ 77.00

+0.00%

FAQ's on ADVIKLA

What is the Market Capitalization of MPS Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 2 June 2025, the market cap for MPS Pharma Ltd. is approximately ₹ 3.2 Cr.

What are the PE and PB ratios for MPS Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for MPS Pharma Ltd. is -3.4, and the Price-to-Book (PB) ratio is 7.4.

What is the 52-Week High and Low for MPS Pharma Ltd.?

Over the past 52 weeks, the highest price reached by MPS Pharma Ltd. shares was ₹ 3.17, and the lowest price was ₹ 1.57.

Who are the major shareholders of MPS Pharma Ltd.?

Significant shareholdings in MPS Pharma Ltd. typically include entities such as:

Public
Promoter
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of MPS Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, MPS Pharma Ltd. is often compared with other major players such as Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs and Corona Remedies for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy